About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Announces Results of TPM Oxycodone Phase 2a Trial

January 29, 2016

Click here to read more

Post navigation

Phosphagenics Reports Positive Resuls for Weaner Pig Efficiency Trial

Phosphagenics Newsletter – February 2016

Related Posts

AGM Chairman’s Address and CEO Presentation

May 28, 2018

Phosphagenics Appoints Three New Directors

April 13, 2015

CEO Quarterly Update

October 4, 2017

Recent Posts

Ethics Approval for CBD Topical Osteoarthritis Study
October 21, 2021
Dosing commences for Phase I human clinical trial
October 4, 2021
Biotech Webinar
September 23, 2021

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.